Definition
Nifurtoinol is a synthetic nitrofuran antimicrobial agent that is primarily employed as a urinary antiseptic for the treatment and prevention of urinary tract infections (UTIs).
Overview
Nifurtoinol belongs to the broader class of nitrofuran antibiotics, which exert their antibacterial effect by interfering with bacterial enzymatic processes and causing damage to bacterial DNA. It exhibits activity against a range of Gram‑positive and Gram‑negative microorganisms commonly implicated in uncomplicated UTIs, such as Escherichia coli and Enterococcus species. The drug is administered orally in tablet form, and its therapeutic action is largely dependent on its concentration in the urine, where it attains bactericidal levels. Clinical use of nifurtoilin has been reported mainly in certain Eastern European and Asian countries; it is not widely marketed in North America or Western Europe.
Etymology/Origin
The name “nifurtoinol” derives from its chemical characteristics: “nitro” refers to the nitro functional group (–NO₂) present in the molecule; “fur” denotes the furan ring, a five‑membered aromatic heterocycle containing oxygen; and the suffix “‑inol” suggests the presence of a hydroxyl (–OH) group. The term reflects the compound’s structural relationship to other nitrofuran derivatives such as nitrofurantoin and nitrofurazone.
Characteristics
- Chemical class: Nitrofuran antibacterial.
- Molecular formula: Reported values vary in the literature; a commonly cited formula is C₈H₆N₂O₅, but accurate confirmation of the exact composition is not universally established.
- Physical properties: Nifurtoinol is a pale‑yellow crystalline solid that is sparingly soluble in water but more soluble in organic solvents such as ethanol.
- Pharmacokinetics: After oral administration, the drug is absorbed from the gastrointestinal tract, undergoes limited hepatic metabolism, and is excreted largely unchanged in the urine, where therapeutic concentrations are achieved.
- Dosage forms: Available primarily as oral tablets (typically 50 mg or 100 mg strengths).
- Adverse effects: Reported side effects include gastrointestinal discomfort (nausea, dyspepsia), allergic skin reactions, and, rarely, pulmonary toxicity or hepatic enzyme elevations, consistent with the safety profile of other nitrofuran agents.
- Regulatory status: Nifurtoinol is approved for medical use in a limited number of countries; it is not listed in the United States Pharmacopeia or the European Medicines Agency’s central database.
Related Topics
- Nitrofurantoin: Another nitrofuran antibiotic widely used for UTIs, with a well‑characterized safety and efficacy profile.
- Nitrofuran antibiotics: A class of synthetic antibacterial agents that includes nitrofurazone, nifuroxazide, and others, known for their broad‑spectrum activity and use in both human and veterinary medicine.
- Urinary tract infection (UTI): A common bacterial infection of the urinary system, often treated empirically with agents such as nitrofurantoin, trimethoprim‑sulfamethoxazole, or nitrofuran derivatives like nifurtoilin.
- Antimicrobial resistance: The emergence of resistance to nitrofuran compounds is an area of ongoing research, influencing the clinical utility of drugs like nifurtoilin.